Detect Cancer Early - Save Lives The HrC Test has made it diagnostically possible for early detection of cancer, due to its focus on embryonic/cancer stem cells. This simple blood test, which is based upon a combination of 8-10 genetic biomarkers, targets key hallmarks of cancer initiation. It is the first prognostic, non-invasive, and safe test for cancer detection, which can be taken as frequently as required. It can assist Oncologists to monitor responsiveness during treatment protocols. It can be used to confirm remission more accurately as compared to all existing methods. This can eventually reduce frequency of invasive and potentially harmful tests like Positron Emission Tomography (PET), Computerised Tomography (CT), etc... The benefits that the HrC Test offers are as follows: a) the ability to detect absence , imminence, or presence of cancer b) a superior test when compared to other liquid-biopsy techniques looking for CTCs, ctDNA, or cfRNA c) the ability to measure patient responsiveness to treatment in a harmless and non-invasive manner d) the ability to confirm remission conclusively, again, in a harmless and non-invasive manner.

medicine

women

politics

The HrC Test - Breakthrough Cancer Blood Test Claims Three Global Firsts.jpg

Steve Smith

facebook

instagram

twitter

<img src="https://cdn.newspage.media/production/company/1817/files/b184a3738a4e6d8563966aa97e0e00d4458220f96fe851d68e3d4fa64e333f33e5e5c86ea35dcf1f73291252ec2d9fb93796bd463bcdac7fdae48fe634b62f2b.webp">Due to a remarkable breakthrough in cancer diagnostics made by a team of scientists in India, we now have a simple blood test for detecting the absence and presence of cancer, The HrC Test. The co-developers of The HrC Test, Singapore-based Tzar Labs and Mumbai-based Epigeneres Biotech, are claiming Three Global Firsts for their technology: i) That this is the first ALL cancer blood test. There are approximately 200 different types of cancer and 3,000 subtypes of cancer. HrC technology can detect ALL of them from a blood sample. Also, HrC technology can detect cancer earlier than any other known technology because HrC can detect cancer when it is PET negative i.e., before Stage 1, and not only can HrC technology detect cancer at this stage with high sensitivity, but it can also advise which cancer i.e., breast, ovarian, lung, colorectal etc…straight from a blood test. ii) That this is the first prognostic test for cancer. HrC can tell a patient that they do not have cancer and that they will not get cancer for the next one year. If HrC indicates that a patient is within a ‘safe zone’, then the fastest cancer cannot go from the ‘safe zone’ to Stage 1 tumour in just one year. The value of this is clear to see, The HrC Test is a blood test we all people need to do once a year whereby cancer will either be detected at Stage 1 or before, when it is infinitely more curable. iii) This one is for the Oncologists. HrC technology can provide the mutation and dysfunctional pathway readings that normally can only be obtained from a biopsy of a tumour tissue. Why is this important? The latest research in the US shows that as soon as you do a tissue biopsy it increases tumour activity. More importantly, sometimes the driver mutation is coming from a second tumour and not the tumour where the tissue biopsy had been performed. In this instance, there will be no readings obtained for the second tumour. With HrC Technology, readings for ALL tumours that exist in the patient will be obtained, straight from a blood sample. Accendo Supplies is exclusively licensed by Tzar Labs to introduce their HrC technology into the UK. To learn more about The HrC Test, including how to arrange a test, please visit our website at <a href="www.thehrctest.co.uk">www.thehrctest.co.uk</a> &nbsp;<blockquote>There is almost a feeling of inevitability that The HrC Test will become the test of choice when it comes to screening the UK population for Cancer</blockquote>

Breakthrough Cancer Blood Test Claims Three Global Firsts

Due to a remarkable breakthrough in cancer diagnostics, it is now possible to detect the absence or presence of cancer using a simple blood test, The HrC Test. The HrC Test is an early cancer detection test that is highly effective in detecting early-stage cancers but one of the most amazing attributes of this cancer-detecting blood test is the fact that it can give a result for cancer not being present in the human body.&nbsp; This is due to The HrC Test being able to measure changes in biomarker activity which occur when cancer is detected. These biomarkers are always present in peripheral blood which means with The HrC Test there is always a result. Therefore, no measurable change in biomarker activity means that cancer is not present. Why is having a good ‘rule out’ cancer blood test so important? During 2020/21, there were 2,073,624 Urgent Suspected Cancer Referrals made in England, resulting in 135,163 cancer cases. There are two ways of looking at these figures. One is that we are blessed that only ~6.5% of those referrals resulted in a cancer diagnosis. The other is that ~93.5% of those referrals did not have cancer but their symptoms still needed to be investigated by cancer specialists before receiving the all-clear. This undoubtedly puts the NHS under an extreme amount of pressure in terms of the level of resources required to undertake this mammoth task, especially at a time when the NHS is facing major challenges due to workforce shortages across speciality roles.&nbsp; With the number of Urgent Suspected Cancer Referrals predicted to rise over the coming years, and combined with ongoing workforce shortages, it is a pressure that is only going to increase. For patients, this pressure slows down the whole process with the ultimate delay being in receiving treatment for those patients who are unfortunate enough to be diagnosed with the disease. The amount of anxiety that these delays can cause must at times be unbearable for those concerned. Therefore, a highly effective cancer blood test for ruling out cancer as a cause of illness with test results delivered promptly is essential if the NHS is going to be unburdened by this immense pressure. Such a cancer-detecting blood test would allow cancer specialists to focus their attention on treating those patients who have cancer. Why The HrC Test? The HrC Test is a simple blood test, only requiring a 10ml sample of blood for processing. The blood sample can be collected in Primary Care or a Rapid Diagnostic Centre or Community Diagnostic Centre without the need of involving Secondary Care. Results of The HrC Test are typically available within a few days making it one the quickest methods of obtaining a definitive cancer absent or cancer present result. This will allow GPs the opportunity to quickly turn their attention to other possible causes of illness for those patients where the result of The HrC Test is ‘cancer absent’. For those patients where the result of The HrC Test is ‘cancer present’ they can be referred to a fast-track cancer clinic so that they can start their cancer treatment as quickly as possible. The HrC Test potentially offers a simple and effective solution to what is rapidly becoming a major problem for the NHS and its patients by moving the detection of cancer from a Secondary Care setting and putting it into a Primary Care setting. &nbsp;<blockquote>If we are to stop the NHS from sinking under the sheer volume of people being referred suspected of cancer who do not have the disease, then something needs to change. The method for determining that a patient does not have cancer needs to be simplified. The HrC Test is the only test that can give a "cancer-free" result. In short, the NHS needs The HrC Test.</blockquote>

Blood Test ‘Rules Out’ Cancer as a Cause of Illness

A new blood test for cancer, The HrC Test, is being introduced to the UK by a Doncaster-based business, Accendo Supplies, who were amongst the first to recognise the diagnostic potential of this new technology. In a 1000-subject clinical trial conducted in India, consisting of 500 cancer patients and 500 non-cancer patients, The HrC Test successfully detected all 500 cancer patients and all 500 non-cancer patients, with the 500 cancer patients encompassing 25 different types of cancer including: Breast, Liver, Ovarian, Lung, Leukemia, Renal, Bladder, Prostate, Pancreatic, Cervical, Colon etc… “When we first came across The HrC Test we were struck by the potential of having one test to detect all cancers. However, equally as important was to have a test that could definitively rule out cancer as a cause of illness, to definitively advise people that they are cancer-free. We are currently working on arranging studies in the UK as to further evaluate the performance of this remarkable technology with a view to making the test available in the UK as quickly as possible. In our opinion, we have finally found the right technology to enable earlier detection &amp; diagnosis of cancer”. (Steve Smith, Co-Founder &amp; Director, Accendo Supplies Limited). The developers of the test claim that their technology can detect every type of cancer earlier than any other known technology, even prior to symptoms and tumour development. This makes The HrC Test the ideal test for cancer screening programmes in the UK. More information about The HrC Test can be found at www.thehrctest.co.uk &nbsp;<blockquote>“The HrC Test offers us the opportunity to no longer be fearful of cancer as the disease can no longer hide from us, the challenge now is to turn this opportunity into reality for the benefit of all”.</blockquote>

New Blood Test Detects 25 Different Types of Cancer

The HrC Test is a simple blood test that can detect cancer at Stage I or before, which is earlier than any other known technology. We are raising funds on the Crowdfunder platform so that we can make this test available to the people of the UK. Please give your support and help us to prevent the 1000's of people who needlessly die each year due to late diagnosis of cancer. https://www.crowdfunder.co.uk/p/the-hrc-test<blockquote>The HrC Test represents a remarkable breakthrough in cancer diagnostics and is certainly a test that we all need to do once a year. This way we will start catching cancer early i.e. Stage I or before, when it is infinitely more curable"</blockquote>

Catching Cancer Early

Detect Cancer Early - Save Lives The HrC Test has made it diagnostically possible for early detection of cancer, due to its focus on embryonic/cancer stem cells. This simple blood test, which is based upon a combination of 8-10 genetic biomarkers, targets key hallmarks of cancer initiation. It is the first prognostic, non-invasive, and safe test for cancer detection, which can be taken as frequently as required. It can assist Oncologists to monitor responsiveness during treatment protocols. It…

has been added

Address

Media Pack / Portfolio

Steve Smith

Media Coverage

No media coverage has been added yet